Aalto's bone lengthening treatment spinout Synoste has been snapped up after raising funding from investors including Evonik and Mectalent.
Synoste, a Norway-based orthopaedic bone lengthening technology spinout of Aalto University, has been acquired by medical device manufacturer Globus Medical in a deal enabling specialty chemicals producer Evonik to exit.
Founded in 2012, Synoste has created an orthopaedic implant for treating patients with leg length deformities.
The implant is made using malleable polymer materials supplied by Evonik and can be modulated through a wireless device to gently stretch out the bone in the patient’s shorter leg.
Globus…
